TABLE 3.
ATP analysis of malaria incidence during a 3-month period from the time of the first round of SMCa
| Group and treatment | No. of participants | No. of cases | Person-months | Rate (no./1,000/month) | Proportion with malaria (K-M estimate) | SE | OR (95% CI) | Cumulative hazard | SE | HR (95% CI) [P] |
|---|---|---|---|---|---|---|---|---|---|---|
| Fever with parasitemia ≥ 3,000/μl | ||||||||||
| SPAQ | 740 | 119 | 2,175.4 | 54.7 | 0.149 | 0.0127 | 1 | 0.161 | 0.0148 | 1 |
| DHAPQ | 754 | 161 | 2,228.9 | 72.2 | 0.192 | 0.0137 | 1.36 (1.04–1.76) | 0.212 | 0.0168 | 1.31 (0.99–1.74) [0.072] |
| Fever with any parasitemia | ||||||||||
| SPAQ | 740 | 156 | 2,175.4 | 71.7 | 0.193 | 0.0139 | 1 | 0.213 | 0.017 | 1 |
| DHAPQ | 754 | 200 | 2,228.9 | 89.7 | 0.236 | 0.0146 | 1.29 (1.02–1.64) | 0.266 | 0.0188 | 1.25 (0.97–1.62) [0.090] |
a
Abbreviations are as defined for Table 2.